china tr 93 titanium dioxide
North America
Suppliers play a crucial role in transforming these raw materials into usable titanium dioxide. They employ specialized extraction techniques such as the Becher process for ilmenite or the sulfate process for rutile and anatase, which involve chemically treating the ore to produce titanium dioxide. In the sulfate process, for example, the ore is treated with sulfuric acid to form titanyl sulfate, which is then calcined to yield titanium dioxide.
In conclusion, TR 92 titanium dioxide is a versatile and high-performance pigment that offers significant benefits to a wide range of industries. Its exceptional whiteness, opacity, and UV-resistance make it a top choice for manufacturers seeking to enhance the quality and durability of their products. With TR 92 titanium dioxide, businesses can achieve vibrant colors, excellent coverage, and long-lasting performance in their paints, plastics, and paper products.
However, challenges remain for China's talc and titanium dioxide industry. Environmental concerns surrounding the mining and processing of these minerals have led to increased scrutiny from both domestic and international regulators. Additionally, competition from other countries with abundant reserves of these minerals could potentially limit China's market share in the future. Despite these challenges, China's role in the global talc and titanium dioxide market is expected to remain significant, as the country continues to invest in its mining infrastructure and explore new applications for these versatile minerals.
The rise of globalization has also played a role in shaping the TiO2 industry landscape. Manufacturers now operate in a highly competitive international market, necessitating strategic location choices for factories to minimize transportation costs and maximize accessibility to raw materials and customer bases.
...
2025-08-16 13:00
2677
...
2025-08-16 12:36
2031
On November 23, 2022, the General Court of the European Union reversed the conclusion that titanium dioxide was carcinogenic and released a statement (1,2):
“First, the Commission made a manifest error in its assessment of the reliability and acceptability of the study on which the classification was based and, second, it infringed the criterion according to which that classification can relate only to a substance that has the intrinsic property to cause cancer.”
As part of our mission at CRIS we base our safety assessments on the currently available scientific evidence and consider many variables (e.g., study quality, journal of publication, etc.), even if it goes against previous conclusions. Evidence-informed decisions making is critical to ensure that the laws and regulations put into place are for the benefit of the population.
The EU General Court maintains that the scientific evidence presented wasn’t the complete picture for the ingredient, “in the present case, the requirement to base the classification of a carcinogenic substance on reliable and acceptable studies was not satisfied.”
...
2025-08-16 12:22
815
On November 23, 2022, the General Court of the European Union reversed the conclusion that titanium dioxide was carcinogenic and released a statement (1,2):
“First, the Commission made a manifest error in its assessment of the reliability and acceptability of the study on which the classification was based and, second, it infringed the criterion according to which that classification can relate only to a substance that has the intrinsic property to cause cancer.”
As part of our mission at CRIS we base our safety assessments on the currently available scientific evidence and consider many variables (e.g., study quality, journal of publication, etc.), even if it goes against previous conclusions. Evidence-informed decisions making is critical to ensure that the laws and regulations put into place are for the benefit of the population.
The EU General Court maintains that the scientific evidence presented wasn’t the complete picture for the ingredient, “in the present case, the requirement to base the classification of a carcinogenic substance on reliable and acceptable studies was not satisfied.”
“First, the Commission made a manifest error in its assessment of the reliability and acceptability of the study on which the classification was based and, second, it infringed the criterion according to which that classification can relate only to a substance that has the intrinsic property to cause cancer.”
As part of our mission at CRIS we base our safety assessments on the currently available scientific evidence and consider many variables (e.g., study quality, journal of publication, etc.), even if it goes against previous conclusions. Evidence-informed decisions making is critical to ensure that the laws and regulations put into place are for the benefit of the population.
The EU General Court maintains that the scientific evidence presented wasn’t the complete picture for the ingredient, “in the present case, the requirement to base the classification of a carcinogenic substance on reliable and acceptable studies was not satisfied.”